RTL
ENTA icon

Red Tortoise LLC’s Enanta Pharmaceuticals ENTA Stock Holding History

Red Tortoise LLC’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.6K Hold
364
– – ﹤0.01% 395
2025
Q4 		$5.74K Hold
364
– – ﹤0.01% 364
2025
Q3 		$4.36K Hold
364
– – ﹤0.01% 403
2025
Q2 		$2.75K Sell
364
-260
-42% -$1.56K ﹤0.01% 472
2025
Q1 		$3.44K Buy
+624
New +$3.85K ﹤0.01% 412

Other funds holding ENTA

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
SSC
Spruce Street Capital New York $416M AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Red Tortoise LLC's ENTA Position: Q1 2026 in Review

Red Tortoise LLC held its Enanta Pharmaceuticals (ENTA) position steady in Q1 2026 at 364 shares worth $4.6K. The position accounts for ﹤0.01% of the portfolio, ranked #395.

Red Tortoise LLC first reported a position in ENTA in Q1 2025 and has held it in 5 quarters since. The position peaked at $5.74K in Q4 2025. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.

  • Red Tortoise LLC held 364 shares of Enanta Pharmaceuticals worth $4.6K as of Q1 2026.
  • Red Tortoise LLC left its Enanta Pharmaceuticals share count unchanged in Q1 2026.
  • Enanta Pharmaceuticals made up ﹤0.01% of Red Tortoise LLC's portfolio in Q1 2026, its #395 holding.
  • Red Tortoise LLC first reported a position in Enanta Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • Red Tortoise LLC's Enanta Pharmaceuticals position peaked at $5.74K in Q4 2025.
  • 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.

Based on Red Tortoise LLC's 13F filing for Q1 2026, filed 21 Apr 2026.